Hepatocyte growth factor treatment improves alveolarization in a newborn murine model of bronchopulmonary dysplasia

Neonatology

Volumn 95, Issue 4, 2009, Pages 332-338

  Ohki, Yasushi ^a   Mayuzumi, Hiroo ^a   Tokuyama, Kenichi ^b   Yoshizawa, Yukihiro ^a   Arakawa, Hirokazu ^a   Mochizuki, Hiroyuki ^a   Morikawa, Akihiro ^a  

^a GUNMA UNIVERSITY   (Japan)

^b TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Alveolarization; Bronchopulmonary dysplasia; Hepatocyte growth factor; Hyperoxia

Indexed keywords

RECOMBINANT SCATTER FACTOR;

AIRWAY RESISTANCE; AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; DRUG ACTIVITY; HYPEROXIA; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG FUNCTION TEST; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; VASCULARIZATION;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; BRONCHOPULMONARY DYSPLASIA; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HEPATOCYTE GROWTH FACTOR; HUMANS; INFANT, NEWBORN; LUNG; MICE; MICE, INBRED STRAINS; NEOVASCULARIZATION, PHYSIOLOGIC; PULMONARY ALVEOLI; RECOMBINANT PROTEINS; RESPIRATORY FUNCTION TESTS;

ANIMALIA; MURINAE; MUS;

EID: 58149098333     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000187651     Document Type: Article

References (35)

1. Husain AN, Siddiqui NH, Stocker JT: Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29: 710-717.
2. Jobe A: The new BPD: an arrest of lung development. Pediatr Res 1999; 46: 641-643.
3. Abman SH: Bronchopulmonary dysplasia: 'a vascular hypothesis'. Am J Respir Crit Care Med 2001; 164:1755-1756.
4. Bourbon J, Boucherat O, Chailley-Heu B, Delacourt C: Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 2005; 57:38-46.
5. Amy R, Bowes D, Burri P, Haines J, Thurl-beck WM, Muller NL: Postnatal growth of the mouse lung. J Anat 1977; 124:131-151.
6. Burri P: Fetal and postnatal development of t he lung. Annu Rev Physiol 1984; 46: 617- 628.
7. Warner BB, Stuart LA, Papes RA, Wispe JR: Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998; 275:L110-L117.
8. Wilson WL, Mullen M, Olley PM, Rabinovitch M: Hyperoxia-induced pulmonary vascular and lung abnormalities in young rats and potential for recovery. Pediatr Res 1985; 19:1059-1067.
9. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikuhara Y: Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81:414-419.
10. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Takahashi K, Koura M, Hashimoto S, Daikuhara Y: Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res 1986; 166: 139 -150.
11. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T: Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 1993; 268: 21212 -21217.
12. Ishizawa K, Kubo H, Yamada M, Kobayashi S, Suzuki T, Mizuno S, Nakamura T, Sasaki H: Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem Bio-phys Res Commun 2004; 324:276-280.
13. Padela S, Cabacungan J, Shek S, Belcastro R, Yi M, Jankov RP, Tanswell AK: Hepatocyte growth factor is required for alveologenesis in the neonatal rat. Am J Respir Crit Care Med 2005; 172:907-914.
14. Ohmichi H, Koshimizu U, Matsumoto K, Nakamura T: Hepatocyte growth factor acts as a mesenchyme-derived morphogenic factor during fetal lung development. Development 1998; 125:1315-1324.
15. Lassus P, Janera J, Haglunda C, Karikoskia R, Andersson LC, Andersson S: Consistent expression of HGF and c-met in the perinatal lung. Biol Neonate 2006; 90: 28-33.
16. Lassus P, Heikkila P, Andersson LC, von Boguslawski K, Andersson S: Lower concentration of pulmonary hepatocyte growth factor is associated with more severe lung disease in preterm infants. J Pediatr 2003; 143: 199- 202.
17. Sakamaki Y, Matsumoto K, Mizuno S, Miyoshi S, Matsuda H, Nakamura T: Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice. Am J Respir Cell Mol Biol 2002; 26: 525-533.
18. Dohi M, Hasegawa T, Yamamoto K, Marshall BC: Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis. Am J Respir Crit Care Med 2000; 16 2: 2302-2307.
19. McGrath-Morrow S, Stahl J: Apoptosis in neonatal murine lung exposed to hyperoxia. Am J Respir Cell Mol Biol 2001; 25: 150-155.
20. Hamelmann E, Schwarze J, Takeda A, Oshiba A, Larsenm GL, Irvin CG, Gelfand EW: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Crit Care Med 1997; 156: 766 -775.
21. Ohki Y, Tokuyama K, Mayuzumi H, Sato A, Koyama H, Takizawa T, Arakawa H, Mochizuki H, Morikawa A: Characteristic features of allergic airway inflammation in a murine model of infantile asthma. Int Arch Allergy Immunol 2005; 138:51-58.
22. Turlbeck WM: The geographic pathology of pulmonary emphysema and chronic bronchitis. I. Review. Arch Environ Health 1967; 14: 16 -2 0.
23. Thurlbeck WM: Internal surface area of normal and emphysematous lungs. Aspen Emphysema Conf 1967; 10:379-393.
24. Cooney TP, Thurlbeck WM: The radial alveolar count method of Emery and Mithal: a reappraisal. 1. Postnatal lung growth. Thorax 1982; 37:572-579.
25. Cooney TP, Thurlbeck WM: The radial alveolar count method of Emery and Mithal: a reappraisal. 2. Intrauterine and early postnatal lung growth. Thorax 1982; 37:580-583.
26. Ohki Y, Tokuyama K, Sato A, Nishimura H, Tabata M, Tomiyoshi K, Inoue T, Arakawa H, Kato M, Mochizuki H, Morikawa A: Maturational changes in airway remodeling after chronic exposure to ovalbumin in sensitized guinea pigs: role of cell renewal of airway resident cells. Pediatr Res 2002; 52: 525-532.
27. Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, Grover TR, et al: Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol 2005; 289:L529-L535.
28. Ono M, Sawa Y, Matsumoto K, Nakamura T, Kaneda Y, Matsuda H: In vivo gene transfection with hepatocyte growth factor via the pulmonary artery induces angiogenesis in the rat lung. Circulation 2002; 106:I264-I269.
29. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106:1311-1319.
30. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Tuder RM, Voelkel NF, Abman SH: Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol 2000; 279:L600-L607.
31. Verghese GM, McCormick-Shannon K, Mason RJ, Matthay MA: Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance. Am J Respir Crit Care Med 1998; 158: 386-394.
32. Saito M, Ichiba H, Yokoi T, Hirai C, Yamano T, Kusuda S: Mitogenic activity of tracheal effluents from premature infants with chronic lung disease. Pediatr Res 2004; 55: 960-965.
33. Panos RJ, Patel R, Bak PM: Intratracheal administration of hepatocyte growth factor/ scatter factor stimulates rat alveolar type II cell proliferation in vivo. Am J Respir Cell Mol Biol 1996; 15: 574-581.
34. Okada M, Sugita K, Inukai T, Goi K, Kagami K, Kawasaki K, Nakazawa S: Hepatocyte growth factor protects small airway epithelial cells from apoptosis induced by tumor necrosis factor-α or oxidative stress. Pediatr Res 2004; 56: 336-344.
35. Shigemura N, Sawa Y, Mizuno S, Ono M, Ohta M, Nakamura T, Kaneda Y, Matsuda H: Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats. Circulation 2005; 111: 1407-1414.